NCT07276386 2026-03-31Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting18 enrolled